vs

Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Sylvamo Corp (SLVM). Click either name above to swap in a different company.

Sylvamo Corp is the larger business by last-quarter revenue ($890.0M vs $617.8M, roughly 1.4× Hims & Hers Health, Inc.). Sylvamo Corp runs the higher net margin — 3.7% vs 3.3%, a 0.4% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -8.2%). Sylvamo Corp produced more free cash flow last quarter ($38.0M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -0.8%).

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

Sylvamo Corp is a leading global manufacturer of sustainable paper and pulp products. Its core offerings include uncoated printing paper, packaging paper, and market pulp, serving office supplies, publishing, commercial printing, and packaging segments across North America, Europe, and Latin America.

HIMS vs SLVM — Head-to-Head

Bigger by revenue
SLVM
SLVM
1.4× larger
SLVM
$890.0M
$617.8M
HIMS
Growing faster (revenue YoY)
HIMS
HIMS
+36.7% gap
HIMS
28.4%
-8.2%
SLVM
Higher net margin
SLVM
SLVM
0.4% more per $
SLVM
3.7%
3.3%
HIMS
More free cash flow
SLVM
SLVM
$40.5M more FCF
SLVM
$38.0M
$-2.5M
HIMS
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
-0.8%
SLVM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HIMS
HIMS
SLVM
SLVM
Revenue
$617.8M
$890.0M
Net Profit
$20.6M
$33.0M
Gross Margin
71.9%
Operating Margin
1.5%
8.9%
Net Margin
3.3%
3.7%
Revenue YoY
28.4%
-8.2%
Net Profit YoY
-20.8%
-59.3%
EPS (diluted)
$0.08
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIMS
HIMS
SLVM
SLVM
Q4 25
$617.8M
$890.0M
Q3 25
$599.0M
$846.0M
Q2 25
$544.8M
$794.0M
Q1 25
$586.0M
$821.0M
Q4 24
$481.1M
$970.0M
Q3 24
$401.6M
$965.0M
Q2 24
$315.6M
$933.0M
Q1 24
$278.2M
$905.0M
Net Profit
HIMS
HIMS
SLVM
SLVM
Q4 25
$20.6M
$33.0M
Q3 25
$15.8M
$57.0M
Q2 25
$42.5M
$15.0M
Q1 25
$49.5M
$27.0M
Q4 24
$26.0M
$81.0M
Q3 24
$75.6M
$95.0M
Q2 24
$13.3M
$83.0M
Q1 24
$11.1M
$43.0M
Gross Margin
HIMS
HIMS
SLVM
SLVM
Q4 25
71.9%
Q3 25
73.8%
Q2 25
76.4%
Q1 25
73.5%
Q4 24
76.8%
Q3 24
79.2%
Q2 24
81.3%
Q1 24
82.4%
Operating Margin
HIMS
HIMS
SLVM
SLVM
Q4 25
1.5%
8.9%
Q3 25
2.0%
11.6%
Q2 25
4.9%
3.8%
Q1 25
9.9%
5.4%
Q4 24
3.9%
11.2%
Q3 24
5.6%
15.5%
Q2 24
3.5%
13.1%
Q1 24
3.6%
8.0%
Net Margin
HIMS
HIMS
SLVM
SLVM
Q4 25
3.3%
3.7%
Q3 25
2.6%
6.7%
Q2 25
7.8%
1.9%
Q1 25
8.4%
3.3%
Q4 24
5.4%
8.4%
Q3 24
18.8%
9.8%
Q2 24
4.2%
8.9%
Q1 24
4.0%
4.8%
EPS (diluted)
HIMS
HIMS
SLVM
SLVM
Q4 25
$0.08
$0.81
Q3 25
$0.06
$1.41
Q2 25
$0.17
$0.37
Q1 25
$0.20
$0.65
Q4 24
$0.10
$1.91
Q3 24
$0.32
$2.27
Q2 24
$0.06
$1.98
Q1 24
$0.05
$1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIMS
HIMS
SLVM
SLVM
Cash + ST InvestmentsLiquidity on hand
$228.6M
$198.0M
Total DebtLower is stronger
$763.0M
Stockholders' EquityBook value
$540.9M
$966.0M
Total Assets
$2.2B
$2.8B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIMS
HIMS
SLVM
SLVM
Q4 25
$228.6M
$198.0M
Q3 25
$345.8M
$146.0M
Q2 25
$1.1B
$183.0M
Q1 25
$273.7M
$220.0M
Q4 24
$220.6M
$309.0M
Q3 24
$165.5M
$414.0M
Q2 24
$129.3M
$213.0M
Q1 24
$105.2M
$218.0M
Total Debt
HIMS
HIMS
SLVM
SLVM
Q4 25
$763.0M
Q3 25
$778.0M
Q2 25
$767.0M
Q1 25
$794.0M
Q4 24
$782.0M
Q3 24
$883.0M
Q2 24
$894.0M
Q1 24
$921.0M
Stockholders' Equity
HIMS
HIMS
SLVM
SLVM
Q4 25
$540.9M
$966.0M
Q3 25
$581.0M
$977.0M
Q2 25
$562.7M
$959.0M
Q1 25
$549.3M
$908.0M
Q4 24
$476.7M
$847.0M
Q3 24
$440.1M
$937.0M
Q2 24
$362.0M
$830.0M
Q1 24
$344.5M
$889.0M
Total Assets
HIMS
HIMS
SLVM
SLVM
Q4 25
$2.2B
$2.8B
Q3 25
$2.2B
$2.7B
Q2 25
$1.9B
$2.7B
Q1 25
$891.7M
$2.6B
Q4 24
$707.5M
$2.6B
Q3 24
$602.3M
$2.9B
Q2 24
$480.5M
$2.7B
Q1 24
$448.1M
$2.6B
Debt / Equity
HIMS
HIMS
SLVM
SLVM
Q4 25
0.79×
Q3 25
0.80×
Q2 25
0.80×
Q1 25
0.87×
Q4 24
0.92×
Q3 24
0.94×
Q2 24
1.08×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIMS
HIMS
SLVM
SLVM
Operating Cash FlowLast quarter
$61.3M
$94.0M
Free Cash FlowOCF − Capex
$-2.5M
$38.0M
FCF MarginFCF / Revenue
-0.4%
4.3%
Capex IntensityCapex / Revenue
10.3%
6.3%
Cash ConversionOCF / Net Profit
2.98×
2.85×
TTM Free Cash FlowTrailing 4 quarters
$57.4M
$44.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIMS
HIMS
SLVM
SLVM
Q4 25
$61.3M
$94.0M
Q3 25
$148.7M
$87.0M
Q2 25
$-19.1M
$64.0M
Q1 25
$109.1M
$23.0M
Q4 24
$86.4M
$164.0M
Q3 24
$85.3M
$163.0M
Q2 24
$53.6M
$115.0M
Q1 24
$25.8M
$27.0M
Free Cash Flow
HIMS
HIMS
SLVM
SLVM
Q4 25
$-2.5M
$38.0M
Q3 25
$79.3M
$33.0M
Q2 25
$-69.5M
$-2.0M
Q1 25
$50.1M
$-25.0M
Q4 24
$59.5M
$100.0M
Q3 24
$79.4M
$119.0M
Q2 24
$47.6M
$62.0M
Q1 24
$11.8M
$-33.0M
FCF Margin
HIMS
HIMS
SLVM
SLVM
Q4 25
-0.4%
4.3%
Q3 25
13.2%
3.9%
Q2 25
-12.8%
-0.3%
Q1 25
8.5%
-3.0%
Q4 24
12.4%
10.3%
Q3 24
19.8%
12.3%
Q2 24
15.1%
6.6%
Q1 24
4.3%
-3.6%
Capex Intensity
HIMS
HIMS
SLVM
SLVM
Q4 25
10.3%
6.3%
Q3 25
11.6%
6.4%
Q2 25
9.3%
8.3%
Q1 25
10.1%
5.8%
Q4 24
5.6%
6.6%
Q3 24
1.5%
4.6%
Q2 24
1.9%
5.7%
Q1 24
5.0%
6.6%
Cash Conversion
HIMS
HIMS
SLVM
SLVM
Q4 25
2.98×
2.85×
Q3 25
9.43×
1.53×
Q2 25
-0.45×
4.27×
Q1 25
2.20×
0.85×
Q4 24
3.32×
2.02×
Q3 24
1.13×
1.72×
Q2 24
4.03×
1.39×
Q1 24
2.32×
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons